About
Articles by Pascale
Activity
-
What an honor to be amongst the TrustCon keynote speakers this year, and in such great company! Join us for a wide ranging conversation about the…
What an honor to be amongst the TrustCon keynote speakers this year, and in such great company! Join us for a wide ranging conversation about the…
Liked by Pascale Witz
-
We’re pleased to welcome renowned rare-disease drug developer Emil Kakkis, M.D., Ph.D., to our board of directors. Dr. Kakkis, a pioneer in rare…
We’re pleased to welcome renowned rare-disease drug developer Emil Kakkis, M.D., Ph.D., to our board of directors. Dr. Kakkis, a pioneer in rare…
Liked by Pascale Witz
-
#Asceneuron_sa announces $100 million oversubscribed Series C financing! Today we announce that we have successfully secured a Series C financing…
#Asceneuron_sa announces $100 million oversubscribed Series C financing! Today we announce that we have successfully secured a Series C financing…
Liked by Pascale Witz
Experience & Education
-
RTI Surgical®
View Pascale’s full experience
See their title, tenure and more.
or
Licenses & Certifications
Publications
-
Tech: The Healthcare Revolution
See publicationIn this Book, Pascale Witz shares why Technology is an accelerator of Medical Innovation in the past, present and future
-
Harnessing the Power of Digital Health
Stern Stewart Institute
See publicationHarnessing the Power of Digital Health describes why Digital Halth is of great support for patients suffering from chronic conditions. Our healthcare systems have been designed to handle acute disease, but now that medicine is allowing us to live longer, many live with chronic medical condition that they have to manage on a daily. DigitalHealth can make it easier for patients to manage their daily lives.
-
Taking the long view
Eyeforpharma
Pascale Witz reveals to Paul Simms, eyeforpharma Chairman, her thoughts on planning, patients & athletics training.
Other authors -
-
Integrated Care
Leaders Magazine
An Interview with Pascale Witz, Executive Vice President, Diabetes & Cardiovascular, Sanofi
Other authors -
-
The Most Powerful Women EMEA
Fortune magazine
See publicationIn 2015, Pascale was listed as one of Fortune’s Most Powerful Women in Europe, the Middle East, and Africa for the second year in a row.
-
Google, Sanofi Join Forces on Diabetes Monitoring and Treatment - WSJ
Wall Street Journal
-
Sanofi s'allie avec Google dans la lutte contre le diabète
Le Monde (french)
-
3 lessons executives can learn from athletes
Fortune
See publicationPascale discusses a “make-or-break” moment in her career, and how her former career as an athlete has shaped her as a leader.
-
Going the distance: Sanofi’s Pascale Witz on driving through change
Pharmaceutical Market Europe
In April 2015, Pascale was included in a PME cover story about Sanofi’s recent product launches, integrated care innovations, and patient-centric culture. Pascale also discusses how her background as a researcher and competitive runner influences her daily work and thinking.
Other authors -
-
What advice would you give someone going into a leadership position for the first time?”
Fortune
See publicationAs one of Fortune’s Most Powerful Women, Pascale regularly contributes to their website. In this post, Pascale gives her advice to first-time managers.
-
Fast Track to the Patient
Pharmaceutical Executive
In January of 2015, Pascale landed on the cover of Pharmaceutical Executive. Here’s the feature story about her innovative, patient-centric integrated care strategy.
Other authors -
-
How to stay excited about your job? Be your own superhero
Fortune
See publicationAs one of Fortune’s Most Powerful Women, Pascale regularly blogs about her job for their website. Pascale here writes about how she stays excited, engaged, and motivated in her job.
-
Le speed-networking, une mesure efficace pour les femmes dans l'entreprise
Les Echos
Here, Pascale speaks to Les Echos about some of her initiatives at Sanofi to encourage female networking and mentorship.
Other authors -
-
The Most Powerful Women of Europe, the Middle East and Africa
Fortune
In 2014, Pascale was listed as one of Fortune’s Most Powerful Women in Europe, the Middle East, and Africa.
Other authors -
Honors & Awards
-
Chevalier de la Legion d'Honneur - Knight of the National Order of the Legion d'Honneur
French Government - Minister of Economy, Mr Emmanuel Macron
-
Most Powerful Women EMEA - Top 20 by Fortune Magazine 2014 and 2015
Fortune Magazine
Nominated as one of the Top 20 Most Powerful Woman in EMEA in 2014 and in 2015.
Languages
-
French
Native or bilingual proficiency
-
English
Native or bilingual proficiency
-
German
-
-
Portuguese
-
Organizations
-
World Economic Forum
Member, Global Agenda Council for the Future of Healthcare
- Present -
French American Foundation FRANCE
Board Member
- Present
More activity by Pascale
-
Today, we announced the successful completion of an end-of-Phase 2 (EoP2) meeting with the FDA in support of Phase 3 study plans for a treatment for…
Today, we announced the successful completion of an end-of-Phase 2 (EoP2) meeting with the FDA in support of Phase 3 study plans for a treatment for…
Liked by Pascale Witz
-
Very glad to reinforce AUROBAC THERAPEUTICS executive team with such track-record expertise in anti-infectives R&D and expand our activities in the…
Very glad to reinforce AUROBAC THERAPEUTICS executive team with such track-record expertise in anti-infectives R&D and expand our activities in the…
Liked by Pascale Witz
-
Really happy to share JEITO’s new investment in CatalYm GmbH! Since our first investment in the company in November 2022, we have believed in…
Really happy to share JEITO’s new investment in CatalYm GmbH! Since our first investment in the company in November 2022, we have believed in…
Liked by Pascale Witz
-
Join us for an immersive Masterclass to discover CellTolerance, a revolutionary program designed to understand, detect, and treat food intolerance…
Join us for an immersive Masterclass to discover CellTolerance, a revolutionary program designed to understand, detect, and treat food intolerance…
Liked by Pascale Witz
-
I am particularly proud today, after less than 3 years from starting newcleo, that already more than 750 of our employees in #Europe have seen our…
I am particularly proud today, after less than 3 years from starting newcleo, that already more than 750 of our employees in #Europe have seen our…
Liked by Pascale Witz
-
Biotech lost a bright light early this month when Lisa Burns of Burns McClellan Inc. passed away. Her spirit and intellect connected and energized…
Biotech lost a bright light early this month when Lisa Burns of Burns McClellan Inc. passed away. Her spirit and intellect connected and energized…
Liked by Pascale Witz
-
Mais quel moment de bonheur de partager cette joie avec mes camarades de Flamme à Beauvais aujourd'hui ! C'est le cœur ému que nous nous sommes…
Mais quel moment de bonheur de partager cette joie avec mes camarades de Flamme à Beauvais aujourd'hui ! C'est le cœur ému que nous nous sommes…
Liked by Pascale Witz
-
Today Atara announced that the FDA has accepted its Biologics License Application (BLA) and granted Priority Review with a January 15, 2025 #PDUFA…
Today Atara announced that the FDA has accepted its Biologics License Application (BLA) and granted Priority Review with a January 15, 2025 #PDUFA…
Liked by Pascale Witz
-
#Asceneuron_sa announces $100 million oversubscribed Series C financing! Today we announce that we have successfully secured a Series C financing…
#Asceneuron_sa announces $100 million oversubscribed Series C financing! Today we announce that we have successfully secured a Series C financing…
Liked by Pascale Witz
-
Research from Bain & Company shows “ dealmakers have remained interested in AI-powered and AI enabled healthcare assets, with firms recognizing the…
Research from Bain & Company shows “ dealmakers have remained interested in AI-powered and AI enabled healthcare assets, with firms recognizing the…
Liked by Pascale Witz
-
And in some more financing news, Omega portfolio company Scorpion Therapeutics raised another 150m $ (yes, I know it is the same amount as CatalYm we…
And in some more financing news, Omega portfolio company Scorpion Therapeutics raised another 150m $ (yes, I know it is the same amount as CatalYm we…
Liked by Pascale Witz
-
I am very proud to announce that John Theurer Cancer Center at Hackensack University Medical Center has been named a Top 50 Cancer Program in the…
I am very proud to announce that John Theurer Cancer Center at Hackensack University Medical Center has been named a Top 50 Cancer Program in the…
Liked by Pascale Witz
Other similar profiles
-
Helen Giza
CEO and Chair of the Management Board of Fresenius Medical Care
Connect -
Lammert Albers
Connect -
Jörg Häring
Board Member / Vorstandsmitglied
Connect -
Dr. Christoph Zindel
Connect -
Amina Sabeur
Managing Director / Directrice Générale chez French-American Foundation - France 🇫🇷🇺🇸
Connect -
Francisco Veloso
Connect -
Michael Sen
Connect -
Greg Sorensen
Connect -
Carla Kriwet
Connect -
Craig Cordola, Ed.D, MBA, MHA
Fresenius Medical Care
Connect
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Pascale Witz
-
Pascale WITZ
General Manager at GE Healthcare
-
Pascale Witz
cadre coordonnateur de Pôle chez Gustave Roussy
-
PASCALE NUSSWITZ
--
3 others named Pascale Witz are on LinkedIn
See others named Pascale Witz